Stage 2 is damage to the pancreatic β-cells causing pre-symptomatic hyperglycemia, and stage 3 is overt T1D due to pancreatic β-cell failure with a requirement for exogenous insulin [53]. The gene discussed is INS; the disease is type 1 diabetes mellitus.